Press release
Ibogaine By David Dardashti to Share Groundbreaking Ibogaine Treatment Protocol Insights, Including for Neurodegenerative Conditions and Diabetes, at Psychedelic Science 2025 in Denver
DENVER, CO - May 21, 2025 - Ibogaine By David Dardashti, will be hosting a booth at the upcoming Psychedelic Science 2025 conference, hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS). The conference, a premier global gathering for psychedelic research, medicine, policy, and culture, will take place from June 16-20, 2025, at the Colorado Convention Center.Ibogaine By David Dardashti is expected to share profound insights into specific ibogaine treatment protocols tailored to diverse needs, a hallmark of his approach. This information will delve into the nuanced application of ibogaine for a range of conditions, including:
*
3-Day Treatments: Focused on reflection, treatment initiation, and general wellness, offering a condensed yet impactful experience.
*
7-Day Treatments: Specifically designed for individuals addressing Post-Traumatic Stress Disorder (PTSD), aiming to facilitate deeper emotional processing and healing.
*
7-10 Day Treatments: For general substance abuse.
*
10-14 Day Treatments: Comprehensive protocols for more complex substance abuse dependencies.
*
14-21 Day Inpatient Treatments: Intensive protocols, potentially for individuals requiring extended support for severe substance abuse dependencies or conditions such as:
*
Alzheimer's Disease
*
Dementia
*
Parkinson's Disease
*
Diabetes
Attendees will gain a precise understanding of the ramifications of these specific treatment lengths in relation to an individual's unique needs and circumstances. Dardashti will also illuminate the overall ibogaine experience, explaining its mechanisms and transformative potential with clarity and precision, particularly concerning its application beyond addiction to other challenging health conditions.
Known for his work at Ibogaine by David Dardashti, he has long advocated for individualized care, emphasizing the importance of addressing the root causes of various ailments. His presence at Psychedelic Science 2025 offers a significant opportunity for clinicians, researchers, and the wider psychedelic community to learn about these structured and potentially pioneering approaches to ibogaine therapy.
About David Dardashti:
David Dardashti is a leading expert in ibogaine treatment with extensive experience in developing personalized protocols for addiction, psychological well-being, and other complex health conditions.
About Psychedelic Science 2025:
Psychedelic Science 2025, hosted by MAPS, is the leading international conference dedicated to the study of psychedelic substances for science, medicine, spirituality, and policy. It brings together experts from around the world to share the latest research and developments in the field.
Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ibogaine-by-david-dardashti-to-share-groundbreaking-ibogaine-treatment-protocol-insights-including-for-neurodegenerative-conditions-and-diabetes-at-psychedelic-science-2025-in-denver]
Country: United States
Website: http://www.ibogaineclinic.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ibogaine By David Dardashti to Share Groundbreaking Ibogaine Treatment Protocol Insights, Including for Neurodegenerative Conditions and Diabetes, at Psychedelic Science 2025 in Denver here
News-ID: 4029399 • Views: …
More Releases from ABNewswire
SensePass Named the Leading Dynamics 365 Payment Processing Solution, Trusted by …
SensePass has been recognized as the leading Dynamics 365 payment processing solution, trusted by the largest Microsoft Dynamics 365 customer for global payment operations. With support for 50+ processors through one integration, 100+ global payment methods, and deep integration across Dynamics 365, Commerce, and Business Central, SensePass enables secure, omnichannel payments at enterprise scale.
New York - SensePass today announced its recognition as the leading Dynamics 365 payment processing [https://sensepass.com/microsoft-dynamics-365/] solution,…
Miami Apostilla focuses on accuracy, efficiency, and consistency in preparing do …
Miami Apostilla, led by Chief Executive Officer Bert Rodriguez, continues to expand its apostille and document legalization services to address increasing international documentation needs. Serving individuals, families, and businesses.
Miami Apostilla is strengthening its role as a trusted provider of apostille and document legalization services as international activity continues to increase across South Florida. With Miami serving as a gateway for global commerce, education, immigration, and cultural exchange, the demand for…
Miami Translation Services Strengthens Nationwide Certified Translation Services …
Miami Translation Services has expanded its certified translation services nationwide to meet growing demand for officially recognized document translations. Supporting immigration applicants, legal professionals, universities, and businesses, the company provides certified translations in more than 50 languages. Each document is prepared to comply with federal, judicial, and academic standards, ensuring accuracy, confidentiality, and institutional acceptance across the United States.
In response to increasing national demand for certified document translations, Miami Translation…
Miami Best Roofing Expands High-Performance Roofing Systems to Address South Flo …
Miami Best Roofing, led by owner and CEO Leo Miraldi, has announced the expansion of its residential and commercial roofing services throughout South Florida. The company's enhanced service offerings focus on hurricane resilience, structural longevity, and energy efficiency, responding to increased demand for durable roofing systems in one of the nation's most weather-exposed regions.
Miami Best Roofing, a South Florida-based roofing contractor specializing in residential and commercial projects, has announced a…
More Releases for Ibogaine
Ibogaine by David Dardashti to Illuminate the Transformative Ibogaine Experience …
DENVER, CO - June 20, 2024 - Ibogaine by David Dardashti, a pioneer in holistic Ibogaine therapy, is proud to announce its prominent participation on Day 2 of the highly anticipated Psychedelic Conference 2025. David Dardashti and his team will offer individual descriptions of the unique Ibogaine experience, providing invaluable insights for each and every person at the conference seeking information regarding profound and lasting healing from addiction, trauma, and…
Ibogaine By David Dardashti is Pioneering Brain Wave Research in Ibogaine Treatm …
Renowned ibogaine expert David Dardashti is embarking on groundbreaking research measuring brain wave activity before and after ibogaine treatment. This study aims to shed light on ibogaine's impact on brain function and its potential to promote a more balanced and fulfilling life.
Brain waves are electrical impulses that are produced by the brain and can be measured using an electroencephalogram (EEG). There are four main types of brain waves: alpha, beta,…
Ibogaine By David Dardashti Initiates Ibogaine Data Storage on Google Cloud
Ibogaine By David Dardashti a leading psychedelic treatment center, today announced the commencement of ibogaine patient data storage and analysis on the Google Cloud platform. This initiative aims to leverage machine learning to enhance the precision and safety of ibogaine dosing based on past patient outcomes.
Ibogaine, a naturally occurring psychoactive substance, has shown promise in treating opioid addiction and other mental health conditions. However, its administration requires careful dosing due…
Ibogaine by David Dardashti Offers Proprietary Software to Accelerate Ibogaine R …
Ibogaine by David Dardashti, a renowned pioneer in ibogaine treatment and research, has recently made an exciting announcement regarding the availability of its proprietary software. This software is being offered to contribute to the donations made by Google co-founder towards ibogaine research specifically focused on traumatic brain injury.
This potential for collaboration between Ibogaine by David Dardashti and Google co-founder's donations signifies a significant step forward in the field of ibogaine…
Ibogaine By David Dardashti's Ibogaine Therapy Revolutionized by Questineers' SQ …
Ibogaine By David Dardashti, a leading innovator in the field of ibogaine therapy, today announced a groundbreaking advancement in the optimization of his ibogaine treatment software.
Dardashti's software has revolutionized the way patient data is analyzed by utilizing the power of SQL. Instead of manually sifting through mountains of data, healthcare providers can now simply ask the software specific questions to extract the information they need. This streamlined approach not only…
Ibogaine By David Dardashti Incorporates SQL into Ibogaine Software for Enhanced …
Ibogaine By David Dardashti, a leading provider of innovative solutions in the field of ibogaine therapy, today announced the integration of SQL (Structured Query Language) into its proprietary ibogaine software. This development marks a significant step forward in leveraging the power of data analysis to optimize the ibogaine algorithm for enhanced treatment outcomes
With the integration of SQL, Ibogaine By David Dardashti has significantly enhanced its ability to analyze a vast…
